Actually I believe fair to be closer to $176 - $190 based on my rigorous fundamental and technical analysis and through speaking to industry professionals
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Actually I believe fair to be closer to $176 - $190 based on my...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.39M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 22.0¢ | $43.70K | 194.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77725 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 12270 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 85170 | 0.220 |
4 | 110185 | 0.215 |
8 | 378309 | 0.210 |
5 | 113536 | 0.205 |
14 | 180879 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 50000 | 1 |
0.250 | 200000 | 3 |
0.255 | 125000 | 2 |
0.260 | 25992 | 2 |
0.265 | 15000 | 1 |
Last trade - 15.58pm 12/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online